TABLE 1—
Characteristics | Pre-ACA (n = 339), No. (%) |
Post-ACA (n = 549), No. (%) | P | |
Gender | ||||
Female | 37 (10.9) | 35 (6.4) | .01 | |
Male | 302 (89.1) | 514 (93.6) | ||
Race/ethnicity | ||||
White | 189 (55.8) | 282 (51.4) | .07 | |
Black | 56 (16.5) | 78 (14.2) | ||
Asian | 20 (5.9) | 46 (8.4) | ||
American Indian/Alaska Native | 3 (0.9) | 1 (0.2) | ||
Native Hawaiian/Pacific Islander | 2 (0.6) | 6 (1.1) | ||
Hispanic | 58 (17.1) | 97 (17.7) | ||
Unknown | 11 (3.2) | 39 (7.1) | ||
Age, y | ||||
< 30 | 28 (8.3) | 70 (12.8) | < .01 | |
30–39 | 72 (21.2) | 99 (18.0) | ||
40–49 | 132 (38.9) | 164 (29.9) | ||
50–59 | 96 (28.3) | 175 (31.9) | ||
≥ 60 | 11 (3.2) | 41 (7.5) | ||
Deductible levela | ||||
None | 284 (92.5) | 318 (67.9) | < .01 | |
$1–$999 | 6 (2.0) | 62 (13.2) | ||
≥ $1000 | 17 (5.5) | 88 (18.8) | ||
Payer typea | ||||
Commercialb | 295 (96.1) | 441 (94.2) | .06 | |
Medicaid | 7 (2.3) | 24 (5.1) | ||
Other subsidized programs | 5 (1.6) | 3 (0.6) | ||
HIV clinical markers | ||||
HIV RNA levels BLQ | 243 (73.6) | 415 (79.5) | .05 | |
Clinical AIDS | 134 (39.5) | 209 (38.1) | .67 | |
Exchange members | . . . | 120 (21.9) | < .01 |
Note. ACA = Patient Protection and Affordable Care Act; BLQ = below limits of quantification. The pre-ACA cohort includes members enrolled between January 1, 2012, and June 30, 2012. The post-ACA cohort includes members enrolled between January 1, 2014, and June 30, 2014.
Does not add up to full sample size because of missing values.
Commercial includes large and small employer groups and individual plans.